The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs

被引:49
|
作者
Puckett, Dexter L. [1 ]
Alquraishi, Mohammed [1 ]
Chowanadisai, Winyoo [2 ]
Bettaieb, Ahmed [1 ]
机构
[1] Univ Tennessee Knoxville, Dept Nutr, Knoxville, TN 37996 USA
[2] Oklahoma State Univ, Dept Nutr, Stillwater, OK 74078 USA
关键词
pyruvate kinases; cancer metabolism; metabolic reprogramming; long non-coding RNAs; PYRUVATE-KINASE M2; NF-KAPPA-B; INHIBITS CELL-PROLIFERATION; LUNG-CANCER CELLS; BETA-CATENIN TRANSACTIVATION; HEPATOCELLULAR-CARCINOMA; INSULIN-SECRETION; DOWN-REGULATION; IN-VITRO; C-MYC;
D O I
10.3390/ijms22031171
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pyruvate kinase is a key regulator in glycolysis through the conversion of phosphoenolpyruvate (PEP) into pyruvate. Pyruvate kinase exists in various isoforms that can exhibit diverse biological functions and outcomes. The pyruvate kinase isoenzyme type M2 (PKM2) controls cell progression and survival through the regulation of key signaling pathways. In cancer cells, the dimer form of PKM2 predominates and plays an integral role in cancer metabolism. This predominance of the inactive dimeric form promotes the accumulation of phosphometabolites, allowing cancer cells to engage in high levels of synthetic processing to enhance their proliferative capacity. PKM2 has been recognized for its role in regulating gene expression and transcription factors critical for health and disease. This role enables PKM2 to exert profound regulatory effects that promote cancer cell metabolism, proliferation, and migration. In addition to its role in cancer, PKM2 regulates aspects essential to cellular homeostasis in non-cancer tissues and, in some cases, promotes tissue-specific pathways in health and diseases. In pursuit of understanding the diverse tissue-specific roles of PKM2, investigations targeting tissues such as the kidney, liver, adipose, and pancreas have been conducted. Findings from these studies enhance our understanding of PKM2 functions in various diseases beyond cancer. Therefore, there is substantial interest in PKM2 modulation as a potential therapeutic target for the treatment of multiple conditions. Indeed, a vast plethora of research has focused on identifying therapeutic strategies for targeting PKM2. Recently, targeting PKM2 through its regulatory microRNAs, long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) has gathered increasing interest. Thus, the goal of this review is to highlight recent advancements in PKM2 research, with a focus on PKM2 regulatory microRNAs and lncRNAs and their subsequent physiological significance.
引用
收藏
页码:1 / 55
页数:55
相关论文
共 50 条
  • [31] Exploring the Regulatory Landscape of Dementia: Insights from Non-Coding RNAs
    Kim, Jung-min
    Kim, Woo Ryung
    Park, Eun Gyung
    Lee, Du Hyeong
    Lee, Yun Ju
    Shin, Hae Jin
    Jeong, Hyeon-su
    Roh, Hyun-Young
    Kim, Heui-Soo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [32] Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression
    Ahangar Davoodi, Nasrin
    Najafi, Sajad
    Naderi Ghale-Noie, Zari
    Piranviseh, Ashkan
    Mollazadeh, Samaneh
    Ahmadi Asouri, Sahar
    Asemi, Zatollah
    Morshedi, Mohammadamin
    Tamehri Zadeh, Seyed Saeed
    Hamblin, Michael R.
    Sheida, Amirhossein
    Mirzaei, Hamed
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [33] New insights into the role of long non-coding RNAs in osteoporosis
    Zhang, Weifei
    Liu, Yuheng
    Luo, Yuanrui
    Shu, Xiang
    Pu, Congmin
    Zhang, Bin
    Feng, Pin
    Xiong, Ao
    Kong, Qingquan
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 950
  • [34] Small Non-Coding RNAs in the Human Placenta: Regulatory Roles and Clinical Utility
    Telkar, Nikita
    Stewart, Greg L.
    Pewarchuk, Michelle E.
    Cohn, David E.
    Robinson, Wendy P.
    Lam, Wan L.
    FRONTIERS IN GENETICS, 2022, 13
  • [35] Emerging roles of novel small non-coding regulatory RNAs in immunity and cancer
    Rosace, Domenico
    Lopez, Judith
    Blanco, Sandra
    RNA BIOLOGY, 2020, 17 (08) : 1196 - 1213
  • [36] The regulatory roles of long non-coding RNAs in the development of chemoresistance in breast cancer
    Malhotra, Akshay
    Jain, Manju
    Prakash, Hridayesh
    Vasquez, Karen M.
    Jain, Aklank
    ONCOTARGET, 2017, 8 (66) : 110671 - 110684
  • [37] The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism
    Xu, Yongcan
    Qiu, Mantang
    Shen, Minmin
    Dong, Shunli
    Ye, Guochao
    Shi, Xuefei
    Sun, Ming
    MOLECULAR THERAPY, 2021, 29 (07) : 2209 - 2218
  • [38] The Regulatory Roles of Non-coding RNAs in Angiogenesis and Neovascularization From an Epigenetic Perspective
    Alejandra Hernandez-Romero, Itzel
    Guerra-Calderas, Lissania
    Salgado-Albarran, Marisol
    Maldonado-Huerta, Tatiana
    Soto-Reyes, Ernesto
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [39] Non-coding RNAs in the reprogramming of glucose metabolism in cancer
    Shankaraiah, Ram C.
    Veronese, Angelo
    Sabbioni, Silvia
    Negrini, Massimo
    CANCER LETTERS, 2018, 419 : 167 - 174
  • [40] The gene regulatory role of non-coding RNAs in non-obstructive azoospermia
    Zhou, Guanqing
    Zhang, Mimi
    Zhang, Jingzhi
    Feng, Yaofeng
    Xie, Zhishen
    Liu, Siyi
    Zhu, Detu
    Luo, Yumei
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13